查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439608

血管內超音波 (IVUS) - 全球市場回顧、競爭格局、市場預測 (2030)

Intravascular Ultrasound (IVUS) - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年，全球血管內超音波（IVUS）市場規模將達到7.1485億美元，到2030年將達到10.6526億美元，2024-2030年預測期間複合年增長率為7.10%，預計增長。 血管內超音波 (IVUS) 的需求主要由心血管疾病 (CVD) 盛行率的上升和肥胖、糖尿病和高血壓等危險因素以及技術進步和產品發佈的不斷增加所推動。對2024-2030 年預測期內的市場成長產生正面影響。

血管內超音波 (IVUS) 市場動態

由於冠心病、週邊動脈疾病和腦血管疾病等心血管疾病的盛行率不斷上升，血管內超音波（IVUS）市場的產品需求呈現成長態勢。這些是超音波（IVUS）市場的關鍵驅動因素） 市場。

根據美國心臟協會 (2022) 的數據，2020 年全球約有 2.441 億人患有冠心病（缺血性心臟病）。 同一消息來源稱，2020年，北非、中東、中亞、南亞和東歐是全球冠心病（缺血性）心臟病患病率最高的地區。

根據英國心臟基金會（2022）的數據，2019年全球約有5.5億人（每14人中就有1人）患有心臟和循環系統疾病，其中包括約2.9億女性和約2.6億男性。

肥胖、高血壓、糖尿病、吸菸、老年、飲酒、不健康的生活方式、動脈粥狀硬化等危險因子增加是心血管疾病發生的主要原因，而血管內超音波（IVUS）進一步推動市場成長。

根據世界衛生組織（2023）的數據，2020年，全球約有10億人年齡在60歲以上。 預計到 2050 年，60 歲及以上的老年人口將增加一倍，達到約 21 億人。 此外，預計 2020 年至 2050 年間，80 歲及以上的人口數量將增加兩倍，達到 4.26 億人。

此外，根據國際糖尿病聯盟（2022）發佈的數據，到2022年，大約有5.37億20歲至79歲的成年人將患有糖尿病。 根據世界肥胖聯合會提供的最新數據，2020年全球約有7.7億人受到肥胖影響，預計2030年將超過10億人。

因此，由於上述心血管疾病及其相關危險因子的增加，CVD的盛行率將會增加，血管內超音波（IVUS）市場在2024-2030年研究期間將會成長。

此外，新 IVUS 產品上市核准等產品開發活動預計將進一步推動全球血管內超音波 (IVUS) 市場的成長。 2020年2月，Conavi Medical Inc.和Japan Lifeline宣佈，他們的Novasight混合血管內影像系統獲得日本厚生勞動省的監管批准。

然而，光學相干斷層掃瞄 (OCT) 和血管造影等替代技術的存在以及多次產品召回可能會抑制血管內超音波 (IVUS) 設備市場的成長。

COVID-19 大流行對血管內超音波 (IVUS) 市場的成長產生了輕微的負面影響，在最初的幾個月裡，由於封鎖指令和邊境關閉，IVUS 市場的製造、供應、進出口以及其他相關活動受到阻礙。

世界各地也暫停了 COVID-19 以外的健康問題（包括心血管疾病）的診斷和治療。

醫院、診所和其他醫療機構因管理和治療 COVID-19 患者而負擔過重。 因此，主要基於 IVUS 的診斷服務被停止，對血管內超音波 (IVUS) 市場的成長產生了負面影響。 重症 COVID-19 患者有影響心血管系統的其他肺部症狀，但使用其他現成且易於使用的影像方式（例如 X 光和 CT）可能比 IVUS 更受青睞。這一點很明顯。 然而，隨著疫苗的推出、COVID-19疫苗接種的普及以及包括醫療部門在內的工業活動的恢復，血管內超音波（IVUS）市場將在未來幾年復甦，並且IVUS市場的預測是積極的。

本報告提供了全球血管內超音波 (IVUS) 市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第1章血管內超音波 (IVUS) 市場報告簡介

第 2 章血管內超音波 (IVUS) 市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估

第3章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章血管內超音波（IVUS）市場主要因素分析

  • 血管內超音波 (IVUS) 市場驅動因素
    • 各種危險因子導致心血管疾病 (CVD) 盛行率不斷上升
    • 由於最新的技術進步，IVUS 得到了廣泛採用
    • 由於 PCI 手術而廣泛使用 IVUS
  • 血管內超音波 (IVUS) 市場的限制和挑戰
    • 存在光學相干斷層掃瞄 (OCT) 和血管攝影等替代方案
    • 多項產品召回阻礙市場成長
  • 血管內超音波 (IVUS) 市場機會
    • 將人工智慧進步融入血管內超音波
    • 大公司的收購、聯盟和研發等策略活動激增

第 5 章血管內超音波 (IVUS) 市場的波特五力分析

第6章COVID-19對血管內超音波（IVUS）市場的影響分析

第7章血管內超音波（IVUS）市場佈局

  • 依類型
    • IVUS 控制台
    • IVUS導管
  • 依用途
    • 冠狀動脈介入治療
    • 週邊血管介入治療
  • 按最終用戶
    • 醫院、診所
    • 影像診斷中心
    • 其他
  • 按地區
    • 北美血管內超音波 (IVUS) 市場規模（2021-2030 年）
    • 歐洲血管內超音波 (IVUS) 市場規模（2021-2030 年）
    • 亞太地區血管內超音波 (IVUS) 市場規模（2021-2030 年）
    • 其他地區血管內超音波 (IVUS) 市場規模（2021-2030 年）

第 8 章血管內超音波 (IVUS) 市場公司與產品概況

  • Koninklijke Philips N.V
  • Boston Scientific Corporation
  • Terumo Corporation
  • Nipro
  • Conavi Medical
  • Bracco
  • Intravascular Imaging Incorporated (i3)
  • Insight Lifetech Co., Ltd.
  • Shanghai Pulse Medical Technology Inc.

第9章KOL瀏覽量

第 10 章專案方法

第 11 章關於 DelveInsight

第 12 章免責聲明與聯絡我們

Product Code: DIMDCL0441

Intravascular Ultrasound (IVUS) Market By Type (IVUS Consoles And IVUS Catheters), By Application (Coronary And Peripheral Interventions), By End-User (Hospitals And Clinics, Diagnostic Imaging Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of cardiovascular diseases and its associated risk factors such as obesity, diabetes, high blood pressure, among others

Global Intravascular Ultrasound (IVUS) Market was valued at USD 714.85 million in 2023, growing at a CAGR of 7.10% during the forecast period from 2024 to 2030 to reach USD 1,065.26 million by 2030. The demand for Intravascular Ultrasound (IVUS) is primarily being boosted due to the rising prevalence of cardiovascular diseases (CVDs) and its risk factors such as obesity, diabetes, and high blood pressure, increasing technological advancements coupled with increasing product launches, that are expected to create a positive impact on the market growth during the forecast period from 2024-2030.

Intravascular Ultrasound (IVUS) Market Dynamics:

The Intravascular Ultrasound (IVUS) market is witnessing a growth in product demand owing to the rising prevalence of cardiovascular diseases including coronary heart disease, peripheral arterial disease, and cerebrovascular disease, among others, becoming a major market driver for the intravascular ultrasound (IVUS) market.

According to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020. As per the same source, North Africa, the Middle East, Central and South Asia, and Eastern Europe had the highest prevalence rates of coronary (ischemic) heart disease in the world in 2020.

As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men.

The increasing number of risk factors such as obesity, hypertension, diabetes, smoking, old age, alcohol consumption, unhealthy lifestyle, atherosclerosis, and others is the main reason for the development of cardiovascular diseases further driving the market growth for intravascular ultrasound (IVUS).

According to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The elderly population aged 60 and above is expected to double in number representing about 2.1 billion people by 2050. Also, people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million.

Furthermore, the data published by International Diabetes Federation 2022 stated that around 537 million adults aged between 20 and 79 years were suffering from diabetes in 2022. As per the latest data provided by World Obesity Federation, obesity affected about 770 million people globally in 2020 and this number is expected to exceed one billion by 2030.

Thus, owing to the increased cases of cardiovascular diseases and their associated risk factors mentioned above, the prevalence of CVD will increase, which will drive the intravascular ultrasound (IVUS) market growth during the study period from 2024-2030.

Moreover, product development activities such as approvals for new IVUS launched products are further expected to aid in the growth of the global Intravascular Ultrasound (IVUS) market. In February 2020, Conavi Medical Inc. and Japan Lifeline announced that they received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for the Novasight Hybrid intravascular imaging system.

However, the presence of alternatives such as optical coherence tomography (OCT) and angiography, along with multiple product recalls may restrict the intravascular ultrasound (IVUS) devices market growth.

The COVID-19 pandemic had a slightly negative impact on the market growth of intravascular ultrasound (IVUS) as during the initial few months owing to the lockdown impositions, border closures, the manufacturing, supply, import, export, and other related activities of the IVUS market was hampered.

The diagnosis as well as treatment for health problems including cardiovascular diseases, other than COVID-19 was also suspended around the globe.

The hospitals, clinics, and other medical facilities were overburdened with managing and treating patients affected with COVID-19. This caused a halt on major IVUS based diagnostic services, thereby negatively affecting the intravascular ultrasound (IVUS) market growth. Though, in severe COVID cases extra pulmonary manifestations affecting cardiovascular system were observed, but the use of other easily available and accessible imaging modalities such as X-ray and CT were more prominent than IVUS. However, with the introduction of vaccines and masses being vaccinated against COVID- 19 and owing to the resumption of activities in industries including the healthcare sector, the market for intravascular ultrasound (IVUS) is set to recover in the upcoming years displaying a positive forecast for the IVUS market.

Intravascular Ultrasound (IVUS) Market Segment Analysis:

Intravascular Ultrasound (IVUS) Market by Type (IVUS Consoles and IVUS Catheters), Application (Coronary and Peripheral Interventions), End-User (Hospitals and Clinics, Diagnostic Imaging Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment, IVUS catheters segment is expected to have a revenue share of 66.65% in the year 2023. This can be ascribed to the applications of IVUS catheters in interventional cardiology and the recent product launches in the IVUS catheters sector.

IVUS catheters are composed of miniaturized transducer that via the use of sound waves helps in obtaining the images of coronary and peripheral arteries and then transmits the image to a dedicated console for image analysis.

These IVUS catheters can be either solid state (phased electronic array) or rotational (mechanical). Solid state IVUS catheters offer advantage for a broad depth of field and are suitable for analysis of larger vessels such as for peripheral interventions. These solid state multiple element catheters are composed mainly of mobile parts, are easy to set up and use. For example, Eagle eye(TM) by Koninklijke Philips N.V., is a solid state catheter with 64 separate transducer elements.

In addition, recent product launches in this sector are also expected to drive the demand for IVUS catheters in the upcoming years. In July 2022, I3 launched its proprietary 3-French NIRF-IVUS Catheter designed in collaboration with Massachusetts General Hospital; combining intravascular ultrasound, the dominant imaging approach used for coronary stent optimization during percutaneous coronary intervention (PCI), with near-infrared fluorescence imaging.

Therefore, the various advantages offered by IVUS catheters along with product launches, are predicted to contribute to increase in the overall demand for this product type, thereby driving the growth of the overall intravascular ultrasound (IVUS) market during the forecast period.

North America is expected to dominate the overall Intravascular Ultrasound (IVUS) Market:

Among all the regions, North America is expected to hold the largest share of 44.65% in the Intravascular Ultrasound (IVUS) market in 2022. This can be ascribed to the increasing prevalence of various cardiovascular diseases such as peripheral artery disease (PAD), coronary artery disease (CAD), arteriosclerosis, blood clots, among others across the region. The rising research and development activities in the region associated with the launch of new intravascular ultrasound devices, and the strategic business activities by the key players to expand their product portfolio, and others are also driving the market growth in North America.

For instance, the American Heart Association in 2022 projected that by 2035, more than 130 million US adults will have some type of heart disease. PAD which is one of the most prevalent in the US affected around 8.5 million U.S. adults over the age of 40, in 2022. As per the same source, African Americans are twice more likely to screen positive for PAD than non-Hispanic adults.

According to the latest study conducted by Centre of Disease Control and Prevention (CDC), one person dies every 34 seconds in the United States from cardiovascular disease. Also, as per the same source, about 697,000 people in the United States died from heart disease in 2020, in the United States and about 20.1 million adults aged 20 and above had coronary artery disease (CAD).

Along with this, in December 2022, Royal Philips announced that it signed an agreement to acquire Vesper Medical Inc., a developer of minimally invasive peripheral vascular devices based in the United States. Philips stated that the acquisition complements its intravascular ultrasound (IVUS) products for venous imaging.

Thus, the increasing prevalence of various cardiovascular diseases and developmental activities such as merger acquisitions by key players in the IVUS segment will increase the demand for intravascular ultrasound in the North American region, during the forecast period from 2024-2030.

Intravascular Ultrasound (IVUS) Market Key Players:

Some of the key market players operating in the Intravascular Ultrasound (IVUS) market include Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Nipro, Conavi Medical, Bracco, Intravascular Imaging Incorporated (i3), Insight Lifetech Co., Ltd., Shanghai Pulse Medical Technology Inc., and others.

Recent Developmental Activities in the Intravascular Ultrasound (IVUS) Market:

In September 2022, Insight Lifetech was granted NMPA (National Medical Products Administration) approval for its first self-designed and developed IVUS (Intravascular Ultrasound) systems- VivoHeart IVUS console and TrueVision IVUS Imaging Catheter.

In December 2022, Conavi Medical Inc., entered into agreements for over $20 million in funding to support commercialization and growth of its innovative Novasight Hybrid® System for market. The company aimed to raise an additional $10 million as part of an ongoing financing effort.

In April 2022, Nipro Medical Corporation (NMC), announced the creation of a Vascular Division in the U.S. The division included several cutting-edge technologies, innovative vascular and cardiovascular products to provide clinicians with procedural and imaging solutions that enhance patient care. The division will include intravascular imaging technologies, vascular therapies, and breakthrough technologies.

Key Takeaways from the Intravascular Ultrasound (IVUS) Market Report Study

Market size analysis for current Intravascular Ultrasound (IVUS) market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Intravascular Ultrasound (IVUS) market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Intravascular Ultrasound (IVUS) Market.

Various opportunities available for the other competitor in the Intravascular Ultrasound (IVUS) Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current Intravascular Ultrasound (IVUS) market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Intravascular Ultrasound (IVUS) market growth in the coming future?

Target Audience who can be benefited from this Intravascular Ultrasound (IVUS) Market Report Study

Intravascular Ultrasound (IVUS) products providers

Research organizations and consulting companies

Intravascular Ultrasound (IVUS)-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Intravascular Ultrasound (IVUS)

Various End-users who want to know more about the Intravascular Ultrasound (IVUS) market and the latest technological developments in the Intravascular Ultrasound (IVUS) market.

Frequently Asked Questions For The Intravascular Ultrasound (IVUS) Market:

1. What is Intravascular Ultrasound?

Intravascular ultrasound (IVUS), is a catheter-based invasive imaging modality that has applications in interventional cardiology for the characterization of lesion morphology, quantification of plaque burden, stent size guidance, assessment of stent expansion, and in the identification of procedural complications.

2. What is the market for Global Intravascular Ultrasound (IVUS)?

The global Intravascular Ultrasound (IVUS) Market was valued at USD 714.85 million in 2023, growing at a CAGR of 7.10% during the forecast period from 2024 to 2030 to reach USD 1,065.26 million by 2030.

3. What are the drivers for Global Intravascular Ultrasound (IVUS) Market?

The demand for Intravascular Ultrasound (IVUS) is expected to increase substantially due to the rising prevalence of cardiovascular diseases (CVDs) and its risk factors such as obesity, diabetes, and high blood pressure, increasing technological advancements coupled with increasing product launches that are expected to create a positive impact on the market growth during the forecast period 2024-2030.

4. Who are the key players operating in Global Intravascular Ultrasound (IVUS) Market?

Some of the key market players operating in the Intravascular Ultrasound (IVUS) market include Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Nipro, Conavi Medical, Bracco, Intravascular Imaging Incorporated (i3), Insight Lifetech Co., Ltd., Shanghai Pulse Medical Technology Inc., and others.

5. Which region has the highest share in the Intravascular Ultrasound (IVUS) market?

North America is expected to dominate the overall Intravascular Ultrasound (IVUS) market during the forecast period from 2024-2030. This can be ascribed to the increasing prevalence of various cardiovascular diseases such as peripheral artery disease (PAD), coronary artery disease (CAD), arteriosclerosis, blood clots, among others across the region. The rising research and development activities in the region associated with the launch of new intravascular ultrasound devices, and the strategic business activities by the key players to expand their product portfolio, and others are also driving the market growth in North America.

Table of Contents

1.Intravascular Ultrasound (IVUS) Market Report Introduction

2. Intravascular Ultrasound (IVUS) Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Intravascular Ultrasound (IVUS) Market Key Factors Analysis

  • 4.1. Intravascular Ultrasound (IVUS) Market Drivers
    • 4.1.1. Rising incidence of cardiovascular diseases (CVDs) as a result of various risk factors
    • 4.1.2. Better adoption of IVUS owing to recent technological advancements
    • 4.1.3. More prevalent use of IVUS as a result of PCI procedures
  • 4.2. Intravascular Ultrasound (IVUS) Market Restraints and Challenges
    • 4.2.1. Presence of alternatives such as Optical coherence tomography (OCT) and angiography
    • 4.2.2. Multiple product recalls hampering market growth
  • 4.3. Intravascular Ultrasound (IVUS) Market Opportunities
    • 4.3.1. Incorporation of technological AI advances for Intravascular Ultrasound
    • 4.3.2. Surging strategic activities such as acquisitions, partnerships, R&D, and others by key players

5. Intravascular Ultrasound (IVUS) Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Intravascular Ultrasound (IVUS) Market

7. Intravascular Ultrasound (IVUS) Market Layout

  • 7.1. By Type
    • 7.1.1. IVUS Consoles
    • 7.1.2. IVUS Catheters
  • 7.2. By Application
    • 7.2.1. Coronary Interventions
    • 7.2.2. Peripheral Interventions
  • 7.3. By End-User
    • 7.3.1. Hospitals and Clinics
    • 7.3.2. Diagnostic Imaging Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.1.1. United States Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
    • 7.4.2. Europe Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.2.1. France Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.3.1. China Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.3.3. India Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW) Intravascular Ultrasound (IVUS) Market Size in USD million (2021-2030)

8. Intravascular Ultrasound (IVUS) Market Company and Product Profiles

  • 8.1. Koninklijke Philips N.V
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Boston Scientific Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Terumo Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Nipro
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Conavi Medical
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Bracco
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Intravascular Imaging Incorporated (i3)
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Insight Lifetech Co., Ltd.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Shanghai Pulse Medical Technology Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Intravascular Ultrasound (IVUS) Market in Global (2021-2030)
  • Table 4: Intravascular Ultrasound (IVUS) Market in Global by Type (2021-2030)
  • Table 5: Intravascular Ultrasound (IVUS) Market in Global by Application (2021-2030)
  • Table 6: Intravascular Ultrasound (IVUS) Market in Global by End-User (2021-2030)
  • Table 7: Intravascular Ultrasound (IVUS) Market in Global by Geography (2021-2030)
  • Table 8: Intravascular Ultrasound (IVUS) Market in North America (2021-2030)
  • Table 9: Intravascular Ultrasound (IVUS) Market in North America by Country (2021-2030)
  • Table 10: Intravascular Ultrasound (IVUS) Market in the US (2021-2030)
  • Table 11: Intravascular Ultrasound (IVUS) Market in Canada (2021-2030)
  • Table 12: Intravascular Ultrasound (IVUS) Market in Mexico (2021-2030)
  • Table 13: Intravascular Ultrasound (IVUS) Market in Europe (2021-2030)
  • Table 14: Intravascular Ultrasound (IVUS) Market in Europe by Country (2021-2030)
  • Table 15: Intravascular Ultrasound (IVUS) Market in France (2021-2030)
  • Table 16: Intravascular Ultrasound (IVUS) Market in Germany (2021-2030)
  • Table 17: Intravascular Ultrasound (IVUS) Market in the United Kingdom (2021-2030)
  • Table 18: Intravascular Ultrasound (IVUS) Market in Italy (2021-2030)
  • Table 19: Intravascular Ultrasound (IVUS) Market in Spain (2021-2030)
  • Table 20: Intravascular Ultrasound (IVUS) Market in the Rest of Europe (2021-2030)
  • Table 21: Intravascular Ultrasound (IVUS) Market in Asia-Pacific (2021-2030)
  • Table 22: Intravascular Ultrasound (IVUS) Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Intravascular Ultrasound (IVUS) Market in China (2021-2030)
  • Table 24: Intravascular Ultrasound (IVUS) Market in Japan (2021-2030)
  • Table 25: Intravascular Ultrasound (IVUS) Market in India (2021-2030)
  • Table 26: Intravascular Ultrasound (IVUS) Market in Australia (2021-2030)
  • Table 27: Intravascular Ultrasound (IVUS) Market in South Korea (2021-2030)
  • Table 28: Intravascular Ultrasound (IVUS) Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Intravascular Ultrasound (IVUS) Market in the Rest of the World (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Intravascular Ultrasound (IVUS) Market in Global (2021-2030)
  • Figure 4: Intravascular Ultrasound (IVUS) Market in Global by Type (2021-2030)
  • Figure 5: Intravascular Ultrasound (IVUS) Market in Global by Application (2021-2030)
  • Figure 6: Intravascular Ultrasound (IVUS) Market in Global by End-User (2021-2030)
  • Figure 7: Intravascular Ultrasound (IVUS) Market in Global by Geography (2021-2030)
  • Figure 8: Intravascular Ultrasound (IVUS) Market in North America (2021-2030)
  • Figure 9: Intravascular Ultrasound (IVUS) Market in North America by Country (2021-2030)
  • Figure 10: Intravascular Ultrasound (IVUS) Market in the US (2021-2030)
  • Figure 11: Intravascular Ultrasound (IVUS) Market in Canada (2021-2030)
  • Figure 12: Intravascular Ultrasound (IVUS) Market in Mexico (2021-2030)
  • Figure 13: Intravascular Ultrasound (IVUS) Market in Europe (2021-2030)
  • Figure 14: Intravascular Ultrasound (IVUS) Market in Europe by Country (2021-2030)
  • Figure 15: Intravascular Ultrasound (IVUS) Market in France (2021-2030)
  • Figure 16: Intravascular Ultrasound (IVUS) Market in Germany (2021-2030)
  • Figure 17: Intravascular Ultrasound (IVUS) Market in the United Kingdom (2021-2030)
  • Figure 18: Intravascular Ultrasound (IVUS) Market in Italy (2021-2030)
  • Figure 19: Intravascular Ultrasound (IVUS) Market in Spain (2021-2030)
  • Figure 20: Intravascular Ultrasound (IVUS) Market in the Rest of Europe (2021-2030)
  • Figure 21: Intravascular Ultrasound (IVUS) Market in Asia-Pacific (2021-2030)
  • Figure 22: Intravascular Ultrasound (IVUS) Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Intravascular Ultrasound (IVUS) Market in China (2021-2030)
  • Figure 24: Intravascular Ultrasound (IVUS) Market in Japan (2021-2030)
  • Figure 25: Intravascular Ultrasound (IVUS) Market in India (2021-2030)
  • Figure 26: Intravascular Ultrasound (IVUS) Market in Australia (2021-2030)
  • Figure 27: Intravascular Ultrasound (IVUS) Market in South Korea (2021-2030)
  • Figure 28: Intravascular Ultrasound (IVUS) Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Intravascular Ultrasound (IVUS) Market in the Rest of the World (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis